Fill-finish
Fill-finish is a critical final step in the manufacturing of AAV and LV based cell and gene therapies, where product integrity and sterility must be maintained without compromise. Bringing fill-finish in-house enables tighter process control, seamless integration with drug substance manufacturing, and reduced reliance on external partners.
Get in touch Fill-finish is a critical final step in the manufacturing of AAV and LV based cell and gene therapies, where product integrity and sterility must be maintained without compromise. Bringing fill-finish in-house enables tighter process control, seamless integration with drug substance manufacturing, and reduced reliance on external partners.
Our fill-finish services
Bringing fill-finish in-house minimizes technology transfer risks, shortens timelines, strengthens supply chain resilience, and helps ensure the consistent delivery of high-quality clinical and commercial products.
DINAMIQS’ in-house fill- finish solution is a semi- automated SKAN Pure isolator technology equipped with AT Filler Crystal® Pure M1, designed for aseptic vial filling. The technology is specifically well suited for small batches of viral vector DP manufacturing. The isolator is installed in class C environment.
- Dedicated to small batches, designed for novel therapies such as Viral Vectors
- Semi-automated AT-closed vial filling
- Filling format from <1mL to 50mL vials
- AT Vials, specially designed ready-to-fill COC vial
- Oferring fill-finish as stand alone for European release